Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Winston Dunn

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational StudyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Hepatology (Baltimore, Md.)|October 16, 2025
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Hepatology (Baltimore, Md.)|November 13, 2025
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
JHEP Reports : Innovation in Hepatology|July 17, 2023
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitisLuis Antonio Díaz, Eduardo Fuentes-López, Gustavo Ayares, et al.
Hepatology (Baltimore, Md.)|April 12, 2024
An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort studyWinston Dunn, Yanming Li, Ashwani K Singal, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 30, 2026
Diagnostic Accuracy of Non-Invasive Tests for MASLD Across Age, Type 2 Diabetes, and Obesity Subgroups: A Multinational StudyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Hepatology (Baltimore, Md.)|October 16, 2025
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Journal of Hepatology|June 24, 2021
Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJuan Pablo Arab, Luis Antonio Díaz, Natalia Baeza, et al.
Hepatology (Baltimore, Md.)|November 13, 2025
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD studyZobair M Younossi, Leyla de Avila, Salvatore Petta, et al.
Pageof 7